Flu Vaccine - Search News

FDA refuses review of mRNA flu vaccine

Moderna says FDA refuses to review its application for flu vaccine

The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced Tuesday, Feb. 10, marking the latest setback for the development of mRN...

Scientific American · 17h

FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise

· 1d · on MSN

FDA refuses to review Moderna’s mRNA flu vaccine application

· 1d

FDA declines to review Moderna's mRNA flu shot

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday.

· 22h

F.D.A. Refuses to Review Moderna Flu Vaccine

· 19h

Moderna shares fall as FDA declines to review new flu vaccine

· 1d

FDA refuses to review Moderna's influenza vaccine application

In its refusal-to-file letter, the FDA said ‌Moderna's choice to compare mRNA-1010 to an already licensed standard-dose seasonal influenza was the sole reason for the refusal to initiate a review of ...

· 1d

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

· 1d

Moderna says FDA refuses its application for new mRNA flu vaccine

21h

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna

12hon MSN

FDA defends its decision to refuse Moderna's flu vaccine review

By Mariam Sunny and Michael Erman Feb 11 (Reuters) - A U.S. Food and Drug Administration official on Wednesday defended the agency's decision to not review Moderna's experimental flu vaccine application,